BIO KOREA 2023, co-hosted by the Korea Health Industry Development Institute (President Cha Sun-do, hereinafter referred to as the Agency) and Chungcheongbuk-do (Governor Kim Young-hwan, hereinafter referred to as Chungbuk-do) and sponsored by the Ministry of Health and Welfare, was held at COEX in Seoul on the 2023th.
Bio Korea, which celebrates its 18th anniversary this year, runs until Friday the 12th and has grown into Korea’s representative international convention as a venue for technological exchange where excellent technologies in the domestic biohealth field are promoted to the world and practical business discussions between domestic and foreign companies take place. .
Recently, as new markets have been created through the convergence of technologies such as artificial intelligence (AI), digital conversion, and big data, the biohealth industry has been attracting attention as a new growth engine industry by presenting new possibilities in various fields such as disease prevention, diagnosis, and treatment. there is.
At this BIO KOREA 2023, in order to develop the biohealth industry into a convergence and future core strategic industry after the pandemic, various programs such as business partnering, exhibitions, conferences, and investment fairs will be held under the theme of ‘Hyper-connected era, leap to new growth innovative technology’. are going on.
Business partnering, a venue for active technological and business exchanges between companies in the biohealth sector, is expected to be a starting point for creating business results such as technology transfer and investment attraction with the participation of many leading domestic and foreign companies.
Global pharmaceutical companies such as Eli Lilly, Johnson & Johnson, Merck, Boehringer Ingelheim, and Ferring are participating in the business partnering, and domestic companies are also participating. Companies representing the domestic bio industry, including SK Bioscience, Samsung BioLogics, Green Cross, Chong Kun Dang, Hanmi Pharmaceutical, and LG Chemical, will participate. In the case of this business partnering, it is expected that more than 460 meetings with over 1,200 companies have been concluded in advance, opening up an active business arena. During the event period, online meetings will be held 24 hours a day to enable smooth meetings with overseas companies.
The exhibition also saw a significant increase in the number of participating companies compared to the previous year, with a total of 338 companies (102 foreign companies) participating and showcasing the latest technologies from each country. The exhibition operates exhibition halls for each theme, including the contract manufacturing (CMO) and contract development and manufacturing (CDMO) zones, clinical research organization (CRO) zone, advanced regenerative medicine hall, and national hall. In the contract manufacturing (CMO) and contract development and manufacturing (CDMO) zone, Hanmi Pharmaceutical Group, FUJI Film, Wuxi App Tec, etc., and in the clinical trial organization (CRO) zone, LapCorp and IQ, which are competing for the world’s first and second place. Business services provided by country, such as IQVIA, can be found at the booth.
At the country pavilion, you can meet local companies visiting from countries such as Australia, Canada, Germany, Taiwan, and Thailand. The Australian Embassy in Korea and the Canadian Embassy in Korea recruited companies to visit Korea. In Australia, 36 companies in fields such as CDMO, CRO, and microbiome, and in Canada, 11 companies in fields such as AI, precision medicine, anticancer, and cell therapy. Companies participate.
The conference consists of 11 sessions on 21 topics, including regenerative medicine, vaccines, and gene therapy, and about 13 researchers and experts in the biohealth field from 120 countries participate as speakers to share the latest issues and technology business trends encompassing the entire industry. It proceeds through discussion.
After the COVID-19 pandemic, digital innovation brought major changes to the biohealth industry, and the next-generation cutting-edge technology is developing in accordance with accelerated research and development, including ‘digital transformation’ and ‘next-generation clinical trials’ that are emerging, as well as the development of vaccines, regenerative medicine, and AI new drugs. Technical topics are conducted in sessions.
In particular, Jaejun Ryu, general director of Naver Cloud, Korea’s leading medical cloud company, and Dr. Cynthia Verst of IQVIA, the world’s No. 1 new drug development clinical service company, will participate as key speakers, along with other domestic and foreign experts in the field. We look at future innovative technology trends and business status in the biohealth industry and discuss global expansion strategies.
At the Invest Fair, a total of 34 companies and institutions in the biohealth field that research and develop innovative new drugs and medical devices and seek to enter the global market will introduce their excellent technologies, management strategies, and vision to investors.
Presentations and expert discussions will be held in a total of five fields, including regenerative medicine, digital therapeutics, therapeutics, vaccines, and medical devices, and will be held by Boehringer Ingelheim, a global pharmaceutical company, and LapCorp, a global clinical contract research organization (CRO). ), as well as many domestic and foreign companies with excellent technology, such as Ibcell, YBrain, Lego Cam Bioscience, and Mcurex, are participating.
In addition, a special session will be held to provide information on entering the global market, and a total of four countries (USA, Canada, Turkiye, Australia) will present investment trends by country as well as ways to enter the market.
Director Cha Sun-do of the Promotion Agency said, “The biohealth industry is the next-generation power industry that will lead our country in the future, and we hope that this event will serve as a foundation for the domestic biohealth industry to enter the global market by actively exchanging technology and information between domestic and foreign companies.” “He said.
Meanwhile, ‘BIO KOREA 18’, which celebrated its 2023th anniversary this year, was hosted by the Korea Health Industry Development Institute and Chungcheongbuk-do. BIO KOREA, which has been striving to improve the global status and sustainable growth of the Korean health industry since 2006, is solidifying its position as Korea’s representative biohealth international convention with the participation of world-class scholars and business experts every year. BIO KOREA 2023, in collaboration with companies related to the health industry such as domestic and foreign bio, pharmaceuticals, medical devices, cosmetics, and food, as well as interested companies and institutions such as consulting, academia, and related organizations, will be held through various programs such as conferences, business partnering, exhibitions, and investment fairs. It goes on.
→ Go to the BIO KOREA 2023 news special page
